Multiple sclerosis in 2017: Progress in multiple sclerosis - from diagnosis to therapy

Nat Rev Neurol. 2018 Jan 31;14(2):72-74. doi: 10.1038/nrneurol.2018.3.

Authors

Maria Trojano¹, Maria Pia Amato²

Affiliations

¹ Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Italy.
² Department NEUROFARBA, Section Neurosciences, University of Florence, Italy.

PMID: 29384150
DOI: 10.1038/nrneurol.2018.3

No abstract available

MeSH terms

Antibodies, Monoclonal, Humanized / pharmacology*
B-Cell Activating Factor / genetics*
Clemastine / pharmacology*
Humans
Immunologic Factors / pharmacology*
Multiple Sclerosis / diagnosis*
Multiple Sclerosis / drug therapy*
Multiple Sclerosis / genetics

Substances

Antibodies, Monoclonal, Humanized
B-Cell Activating Factor
Immunologic Factors
TNFSF13B protein, human
Clemastine
ocrelizumab